Oliver Staak
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 5
-
- Monoclonal and Polyclonal Antibodies Research 3
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Andreas Engert (5 shared papers)Volker Diehl (4 shared papers)Peter Borchmann (3 shared papers)Roland Schnell (3 shared papers)Hinrich P. Hansen (4 shared papers)Christine Schwartz (1 shared paper)Victor Gheţie (1 shared paper)Ellen S. Vitetta (1 shared paper)
- Journals
- Nuklearmedizin - NuclearMedicine (2 papers)Blood (1 paper)Phytomedicine (1 paper)European Journal Of Haematology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Oliver Staak
8 papers receiving 300 citations
Peers
Comparison fields: 5 of 37
- Pathology and Forensic Medicine 197
- Genetics 53
- Oncology 129
- Immunology 93
- Biotechnology 38
Countries citing papers authored by Oliver Staak
This map shows the geographic impact of Oliver Staak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Staak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Staak more than expected).
Fields of papers citing papers by Oliver Staak
This network shows the impact of papers produced by Oliver Staak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Staak. The network helps show where Oliver Staak may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Staak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. | 2002 | 112 |
| 2 | 2003 | 78 | |
| 3 | 2005 | 48 | |
| 4 | 2005 | 29 | |
| 5 | 2006 | 24 | |
| 6 | 2010 | 8 | |
| 7 | Entwicklung von Anti-CD30-Radioimmunkonstrukten zur Behandlung des Hodgkin-Lymphoms – Studien an Zellkulturen und Tieren | 2010 | 6 |
| 8 | 1996 | 6 |
About Oliver Staak
Oliver Staak is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Immunology, Neurology and Biotechnology, having authored 8 papers that have together received 311 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Transgenic Plants and Applications (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Viral-associated cancers and disorders (1 paper) and Plant Parasitism and Resistance (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (197 citations), Genetics (53 citations), Oncology (129 citations), Immunology (93 citations) and Biotechnology (38 citations). Oliver Staak has collaborated with scholars based in Germany and United States. Frequent co-authors include Andreas Engert, Volker Diehl, Peter Borchmann, Roland Schnell, Hinrich P. Hansen, Christine Schwartz, Victor Gheţie, Ellen S. Vitetta, John Schindler and Andreas Josting. Their work appears in journals such as Nuklearmedizin - NuclearMedicine, Blood, Phytomedicine, European Journal Of Haematology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.